Raymond James Financial Services Advisors
VNRX icon

Raymond James Financial Services Advisors’s VolitionRx Ltd VNRX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-687
Closed -$45K – 3421
2021
Q2 		$45K Buy
+687
New +$46.5K ﹤0.01% 3220

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Raymond James Financial Services Advisors's VNRX Position: Q3 2021 in Review

Raymond James Financial Services Advisors sold out of VolitionRx Ltd (VNRX) in Q3 2021, closing a stake of 687 shares — an estimated $45K sold.

Raymond James Financial Services Advisors first reported a position in VNRX in Q2 2021 and held it in 1 quarter. The position peaked at $45K in Q2 2021. 39 funds tracked by Wall St. Rank hold VNRX as of Q3 2021.

  • Raymond James Financial Services Advisors reported no remaining VolitionRx Ltd position as of Q3 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 687 VolitionRx Ltd shares in Q3 2021, an estimated $45K.
  • Raymond James Financial Services Advisors first reported a position in VolitionRx Ltd in Q2 2021 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's VolitionRx Ltd position peaked at $45K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.